Matches in Wikidata for { <http://www.wikidata.org/entity/Q66393268> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66393268 description "clinical trial" @default.
- Q66393268 description "ensayu clínicu" @default.
- Q66393268 description "klinisch onderzoek" @default.
- Q66393268 description "клінічне випробування" @default.
- Q66393268 name "A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study" @default.
- Q66393268 name "A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study" @default.
- Q66393268 type Item @default.
- Q66393268 label "A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study" @default.
- Q66393268 label "A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study" @default.
- Q66393268 prefLabel "A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study" @default.
- Q66393268 prefLabel "A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study" @default.
- Q66393268 P1050 Q66393268-688B95A8-03B7-4F94-9FF4-78BD225C41B6 @default.
- Q66393268 P1050 Q66393268-E4FBBB9F-C37B-4002-A9B1-D99A9981C969 @default.
- Q66393268 P1050 Q66393268-F67EFB77-B4D1-420A-B530-686B14A25C14 @default.
- Q66393268 P1132 Q66393268-73633198-4803-447A-A657-AEC8F1445EC4 @default.
- Q66393268 P1476 Q66393268-D42616AB-6109-4C26-8C41-333E0E692D7D @default.
- Q66393268 P17 Q66393268-1D886EA9-07FC-4C1C-A32E-A2D18051D4B1 @default.
- Q66393268 P17 Q66393268-371DB07B-02E5-4C01-B45A-44F412D6A879 @default.
- Q66393268 P17 Q66393268-8AA5E8D7-41D8-49C5-9757-7539F883CD88 @default.
- Q66393268 P17 Q66393268-9CBBA40A-CCDD-4C0A-B76F-21C1F2232357 @default.
- Q66393268 P17 Q66393268-9EBA40AE-0D50-4B41-B5F8-218B413AA754 @default.
- Q66393268 P17 Q66393268-A4FB842F-B809-45CB-8E38-F76CF3331855 @default.
- Q66393268 P17 Q66393268-BB069732-4285-49FF-9976-E400839FC49F @default.
- Q66393268 P17 Q66393268-BD431981-3CF9-4598-805D-DD68B1D21197 @default.
- Q66393268 P17 Q66393268-D82119CA-F29D-457A-8C69-8B87649551E9 @default.
- Q66393268 P1813 Q66393268-AD9E4B8B-9A90-48D3-B4F6-C73CD41FB95E @default.
- Q66393268 P2899 Q66393268-00F88C95-3DB6-4D49-8B49-735F07E90D9A @default.
- Q66393268 P3098 Q66393268-27BA3BC5-41F0-4FB0-B337-D02A06350A16 @default.
- Q66393268 P31 Q66393268-0D9A632B-BD6D-401F-A0E5-4BCEFFD61E0E @default.
- Q66393268 P4135 Q66393268-216C2C44-A612-4699-BFA7-EAA703BB817F @default.
- Q66393268 P4844 Q66393268-040339B5-D3EB-4A40-9534-4ECBF867F056 @default.
- Q66393268 P580 Q66393268-2C050959-40CF-425F-9665-7A5301D1C5D3 @default.
- Q66393268 P582 Q66393268-CB3F218D-1446-4591-B131-D84D314FEBFC @default.
- Q66393268 P6099 Q66393268-C4281643-C3BF-4BDF-9BC7-7685FD66EF68 @default.
- Q66393268 P8363 Q66393268-EC938555-5420-4BDA-83E2-B9EBD43B9464 @default.
- Q66393268 P1050 Q131742 @default.
- Q66393268 P1050 Q154869 @default.
- Q66393268 P1050 Q157661 @default.
- Q66393268 P1132 "+50" @default.
- Q66393268 P1476 "An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Chronic Hepatitis C (HCV) Infected Subjects Who Have Experienced Virologic Failure in AbbVie HCV Clinical Studies (MAGELLAN-3)" @default.
- Q66393268 P17 Q145 @default.
- Q66393268 P17 Q16 @default.
- Q66393268 P17 Q183 @default.
- Q66393268 P17 Q29 @default.
- Q66393268 P17 Q30 @default.
- Q66393268 P17 Q34 @default.
- Q66393268 P17 Q39 @default.
- Q66393268 P17 Q408 @default.
- Q66393268 P17 Q664 @default.
- Q66393268 P1813 "MAGELLAN-3" @default.
- Q66393268 P2899 "+12" @default.
- Q66393268 P3098 "NCT02939989" @default.
- Q66393268 P31 Q30612 @default.
- Q66393268 P4135 "+99" @default.
- Q66393268 P4844 Q2502747 @default.
- Q66393268 P580 "2016-11-21T00:00:00Z" @default.
- Q66393268 P582 "2020-06-28T00:00:00Z" @default.
- Q66393268 P6099 Q42824827 @default.
- Q66393268 P8363 Q78089383 @default.